Runyan John S. 4/A
4/A · BIOLARGO, INC. · Filed Jan 10, 2019
Insider Transaction Report
Form 4/AAmended
BIOLARGO, INC.BLGO
Runyan John S.
Director
Transactions
- Award
Option to Purchase Common Stock
2018-12-31+78,125→ 1,309,234 totalExercise: $0.24From: 2018-12-31Exp: 2028-12-31→ Common stock (78,125 underlying)
Footnotes (1)
- [F1]This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the three months ended December 31, 2018, pursuant to the Issuer's 2018 Equity Incentive Plan.